Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-risk Myelodysplastic Syndromes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00910858
What this trial is testing

A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes

Who this might be right for
Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)
Celgene Corporation 40
Early research (Phase 1)Looking for participantsNCT06670222
What this trial is testing

Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Low-risk Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 24
Early research (Phase 1)WithdrawnNCT04176653
What this trial is testing

Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124

Who this might be right for
Non-transfusion-dependent ThalassemiaLow Risk Myelodysplastic Syndrome
Silence Therapeutics plc
Large-scale testing (Phase 3)Active Not RecruitingNCT02598661
What this trial is testing

Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Geron Corporation 289
Testing effectiveness (Phase 2)Study completedNCT03734601
What this trial is testing

Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Disorder+6 more
Stanford University 22
Testing effectiveness (Phase 2)Study completedNCT00053001
What this trial is testing

Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome

Who this might be right for
AnemiaLeukemiaMyelodysplastic Syndromes+1 more
Fallon Clinic
Testing effectiveness (Phase 2)Study completedNCT03011034
What this trial is testing

Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Participants With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Who Are Relapsed or Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment

Who this might be right for
Myelodysplastic Syndromes
Janssen Research & Development, LLC 34
Post-approval studies (Phase 4)UnknownNCT03866681
What this trial is testing

Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02477631
What this trial is testing

Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients

Who this might be right for
Myelodysplastic Syndrome With Low-grade LesionsIron Overload Due to Repeated Red Blood Cell Transfusions
Sheba Medical Center 19
Large-scale testing (Phase 3)Active Not RecruitingNCT05949684
What this trial is testing

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 402
Testing effectiveness (Phase 2)Study completedNCT00095264
What this trial is testing

Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Amgen 209
Testing effectiveness (Phase 2)Study completedNCT00146055
What this trial is testing

Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood

Who this might be right for
Myeloma, Plasma-CellLymphoma, MalignantMyeloproliferative Disorders+2 more
University of Michigan Rogel Cancer Center 60
Early research (Phase 1)Study completedNCT00093743
What this trial is testing

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+8 more
Fred Hutchinson Cancer Center 2
Large-scale testing (Phase 3)Study completedNCT01243476
What this trial is testing

Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
Fundación General de la Universidad de Salamanca 61
Not applicableLooking for participantsNCT04251078
What this trial is testing

Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples

Who this might be right for
Myelodysplastic Syndromes
Josep Carreras Leukaemia Research Institute 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06243458
What this trial is testing

RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms

Who this might be right for
Low Risk Myelodysplastic Syndromes
GCP-Service International West GmbH 41
Testing effectiveness (Phase 2)Ended earlyNCT00486720
What this trial is testing

Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)

Who this might be right for
Myelodysplastic SyndromesBlood DiseaseBone Marrow Disease
Merck Sharp & Dohme LLC 22
Testing effectiveness (Phase 2)Looking for participantsNCT06063486
What this trial is testing

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

Who this might be right for
Clonal Cytopenia of Undetermined SignificanceEssential ThrombocythemiaMyelodysplastic Syndrome+2 more
University of Southern California 30
Testing effectiveness (Phase 2)Ended earlyNCT02943668
What this trial is testing

Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome

Who this might be right for
AnemiaMyelodysplastic Syndrome
Fred Hutchinson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT01244906
What this trial is testing

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

Who this might be right for
Hematologic Neoplasms
Northside Hospital, Inc. 26
Next Page